Characterization and Clinical Impact of the Gut Microbiota in Lymphoma
Recruiting now
Conditions studied: Diffuse Large B Cell Lymphoma
In brief
The study is a prospective observational single-center cohort study which compare the gut microbiome of newly diagnosed Diffuse Large B-cell Lymphoma patients with the gut microbiome of healthy controls. Furthermore the impact of lymphoma treatment, immune phenotypes, cytokine profiles, metabolomics, inflammation, driver mutations, comorbidity, body composition and lifestyle on the microbiome is also investigated
Key facts
- Study ID
- NCT06161896
- Run by
- Lars Møller Pedersen
- People needed
- 200
- Starts
- 2024-05-06
- Expected to finish
- 2026-07-01
- Last updated by the study team
- 2024-08-09
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
Where it is running
- Zealand University Hospital, Department of Hematology — Roskilde, Region Sjælland, Denmark (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.